CAS · 117048-59-6
Product Overview
Combretastatin A4 is a high-purity a-api supplied for industrial and specialty chemical applications. Contact our team for specifications, packaging options and lead times.
Product Specifications
| Appearance | White powder |
|---|---|
| Assay | 97% min |
| Melting point | 84-85 °C |
| Identification | The HPLC RT of sample matches with standard |
| Unspecified impurity (HPLC) | 2% max |
| Petroleum | 20 ppm max |
| Ethyl acetate | 20 ppm max |
| Heavy Metals | 20 ppm max |
| Loss on Drying | 1% max |
Applications
Combretastatin A4 is a potent natural product primarily investigated for its anticancer properties. It functions as a vascular disrupting agent (VDA), targeting and collapsing the blood vessels that supply tumors, thereby inhibiting tumor growth. It is widely studied in preclinical and clinical research for the treatment of various cancers, including solid tumors such as ovarian, thyroid, and lung cancers. In medicinal chemistry, it also serves as a lead compound for the development of analogs and prodrugs with improved solubility and bioavailability. Furthermore, it is used as a biochemical tool to study tubulin dynamics, as it binds to the colchicine site of tubulin and inhibits microtubule assembly.
Benefits
Combretastatin A4 demonstrates strong antitumor activity by selectively targeting tumor vasculature while sparing most normal blood vessels, reducing damage to healthy tissues. Its mechanism of action offers a different approach from conventional chemotherapy, making it a valuable candidate for combination therapy to enhance treatment outcomes. Structural simplicity and modifiability allow researchers to create derivatives that improve pharmacokinetic properties, stability, and clinical applicability. The compound's effectiveness in disrupting microtubules also makes it useful for fundamental cell biology studies.
Conclusion
Combretastatin A4 is a highly significant bioactive compound in oncology research, offering a unique mechanism to inhibit tumor growth through vascular disruption. Its versatility as both a therapeutic candidate and a research tool underscores its importance in drug discovery and cancer biology. Continued study and development of its derivatives hold promise for advancing targeted cancer therapies and improving patient outcomes.
Previous
Streptomycin Sulfate丨CAS 3810-74-0
Next